Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.20.2
Stockholders' Equity
9 Months Ended
Jun. 30, 2020
Stockholders' Equity  
Stockholders' Equity

4.   Stockholders’ Equity

Common Stock Offering

On April 30, 2020, the Company closed an underwritten public offering of 6,037,500 shares of its common stock (inclusive of 787,500 shares that were sold pursuant to the underwriters’ full exercise of their option to purchase additional shares of the Company’s common stock), at a price to the public of $6.00 per share. The Company received net proceeds from the offering of approximately $33.3 million, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes and to advance the development of its product candidates and expand its pipeline.

Warrants

Below is a summary of the Company’s issued and outstanding warrants as of June 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Weighted

 

Average

 

 

 

 

Average

 

Remaining

 

 

 

 

Exercise

 

Contractual Life

 

    

Warrants

    

Price

    

(in years)

Outstanding as of September 30, 2019

 

728,439

 

$

20.99

 

  

Expired

 

(12,500)

 

 

20.00

 

  

Outstanding as of June 30, 2020

 

715,939

 

$

21.01

 

1.77